More than 80% of people living with autoimmune diseases are women. Across the spectrum of conditions — lupus, rheumatoid arthritis, multiple sclerosis, Sjögren’s syndrome, thyroid disease, and dozens of others — the female predominance is consistent and biologically significant. What is less widely understood is the compounding racial disparity embedded within that already-skewed distribution.
Conditions Where Race Multiplies Risk
Lupus is the most documented example, but it is not alone. Multiple sclerosis, once considered less common in Black individuals, is now understood to occur at comparable or higher rates in Black women — with a more aggressive disease course. Rheumatoid arthritis is more prevalent in Native American women. Thyroid autoimmune disease disproportionately affects women of reproductive age across racial groups, with diagnostic delays concentrated among women of color.
The mechanisms underlying these racial disparities are multi-factorial: genetic predisposition, environmental exposures, chronic stress associated with racial discrimination, and differential access to the kind of specialist care that autoimmune diseases require. The relevant literature is growing but remains insufficient to drive the clinical guideline changes that would close the care gap.
The Skin Disease Dimension
Autoimmune skin conditions — including alopecia areata, atopic dermatitis, and psoriatic arthritis — disproportionately affect women and carry quality-of-life burdens that clinical measurement tools have historically undercaptured. SWHR research has highlighted that the burden of skin-related autoimmune disease in women is substantially higher than treatment rates suggest, and that stigma, trivialization of cosmetic symptoms, and access barriers combine to leave many women undertreated.
Alopecia areata — an autoimmune condition causing hair loss — illustrates the problem clearly. It is not considered life-threatening. It is devastating to quality of life, professional confidence, and mental health. For Black women, whose cultural relationship with hair carries specific significance, the condition’s impact is amplified. Clinical guidelines have not incorporated this dimension.
What Equitable Autoimmune Care Requires
Research that enrolls diverse populations in numbers sufficient for race-stratified analyses. Specialist workforce development in underserved communities — rheumatologists, dermatologists, and neurologists are concentrated in urban and high-income areas. Insurance coverage that matches the complexity of autoimmune disease management. And clinical training that does not assume autoimmune disease looks the same in every patient.
The autoimmune gender gap is real. The racial equity gap within it is also real, and it remains underdiscussed relative to its scale.
